Journal article
Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes The TRANSCEND study
Abstract
OBJECTIVE: Several large clinical trials suggest that ACE inhibitors may reduce the incidence of diabetes. Less is known about the effects of angiotensin receptor blockers (ARBs) on reducing incident diabetes or leading to regression of impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) to normoglycemia.
RESEARCH DESIGN AND METHODS: Participants were 3,488 adults at high risk for cardiovascular disease but free from diabetes …
Authors
Barzilay JI; Gao P; Rydén L; Schumacher H; Probstfield J; Commerford P; Dans A; Ferreira R; Keltai M; Paolasso E
Journal
Diabetes Care, Vol. 34, No. 9, pp. 1902–1907
Publisher
American Diabetes Association
Publication Date
September 1, 2011
DOI
10.2337/dc11-0545
ISSN
0149-5992